Outcome and Prognostic Indicators of Patients with Hematopoietic Stem Cell Transplants Admitted to the Intensive Care Unit

Figure 2

Survival in the 6 months following ICU admission is generally better in autologous HSCT patients compared to allogeneic HSCT patients.